Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
15.19
+0.08 (0.53%)
Apr 29, 2026, 3:00 PM CST

SHA:600535 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
1,1611,105955.591,071-264.242,359
Upgrade
Depreciation & Amortization
447.57447.57496.2504.91517.95487.77
Upgrade
Other Amortization
17.0417.046.311.2314.7315.23
Upgrade
Loss (Gain) From Sale of Assets
-8.61-8.61-2.11-0.15-1.48-44.22
Upgrade
Asset Writedown & Restructuring Costs
56.9556.95218.011.78352.26265.48
Upgrade
Loss (Gain) From Sale of Investments
16.7416.74198.5270.751,158-1,682
Upgrade
Provision & Write-off of Bad Debts
20.8820.88-0.238.19-1.34-5.35
Upgrade
Other Operating Activities
715.91-55.15-72.94-2.03-31.24123.82
Upgrade
Change in Accounts Receivable
-522.68-522.6878.221,243535.511,231
Upgrade
Change in Inventory
268.46268.4618.32-220.72-2.86-198.37
Upgrade
Change in Accounts Payable
66.8566.85121.58-395.3536.56243.78
Upgrade
Change in Other Net Operating Assets
---67.7611.013.44
Upgrade
Operating Cash Flow
2,2521,4252,0152,5762,2802,801
Upgrade
Operating Cash Flow Growth
13.20%-29.28%-21.78%12.98%-18.62%56.39%
Upgrade
Capital Expenditures
-273.45-381.26-564.94-668.82-404.41-571.73
Upgrade
Sale of Property, Plant & Equipment
1.37627.581.191.3468.92
Upgrade
Cash Acquisitions
------147.31
Upgrade
Divestitures
-83.38---424.19
Upgrade
Investment in Securities
-1,175-209.9-382.07-134.14-919.91126.42
Upgrade
Other Investing Activities
52.4455.3-21.49-1,30756.7556.76
Upgrade
Investing Cash Flow
-1,395-446.48-940.87-2,109-1,266-42.83
Upgrade
Short-Term Debt Issued
-9701,052213.91102.791
Upgrade
Long-Term Debt Issued
-884.391,4511,8172,7111,441
Upgrade
Total Debt Issued
1,6931,8542,5042,0312,8141,442
Upgrade
Short-Term Debt Repaid
--500-1,132-127-9.87-82.14
Upgrade
Long-Term Debt Repaid
--1,585-2,597-1,345-2,311-2,717
Upgrade
Total Debt Repaid
-1,832-2,085-3,729-1,472-2,321-2,799
Upgrade
Net Debt Issued (Repaid)
-139.15-230.79-1,225559.55492.71-1,358
Upgrade
Repurchase of Common Stock
-----60.8-56.43
Upgrade
Common Dividends Paid
-327.31-632.7-1,042-563.22-553.97-610.49
Upgrade
Other Financing Activities
-510.84493.38-186.05-1,193-114.58-458.73
Upgrade
Financing Cash Flow
-977.3-370.11-2,454-1,196-236.63-2,483
Upgrade
Foreign Exchange Rate Adjustments
-20.16-10.360.16-1.2630.391.94
Upgrade
Net Cash Flow
-140.57597.8-1,380-730.54807.36276.97
Upgrade
Free Cash Flow
1,9781,0431,4501,9071,8752,229
Upgrade
Free Cash Flow Growth
45.27%-28.02%-23.98%1.68%-15.89%61.28%
Upgrade
Free Cash Flow Margin
23.70%12.67%17.06%21.98%21.71%28.04%
Upgrade
Free Cash Flow Per Share
1.320.700.971.281.281.48
Upgrade
Cash Interest Paid
5.515.518.41-4.05-
Upgrade
Cash Income Tax Paid
1,0351,062993.381,0991,1061,008
Upgrade
Levered Free Cash Flow
-616.41840.85968.191,3481,5172,531
Upgrade
Unlevered Free Cash Flow
-596.1861.161,0061,4001,5572,580
Upgrade
Change in Working Capital
-175.63-175.63215.24709.88535.211,281
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.